133 related articles for article (PubMed ID: 11084078)
1. Increasing incidence and pretransplantation screening of hepatocellular carcinoma.
Everson GT
Liver Transpl; 2000 Nov; 6(6 Suppl 2):S2-10. PubMed ID: 11084078
[TBL] [Abstract][Full Text] [Related]
2. [Screening for hepatocellular carcinoma].
Leone N; Rizzetto M
Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
[TBL] [Abstract][Full Text] [Related]
3. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
Amarapurkar D; Han KH; Chan HL; Ueno Y;
J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
[TBL] [Abstract][Full Text] [Related]
4. Viral hepatitis and hepatocellular carcinoma.
Sallie R; Di Bisceglie AM
Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model.
Saab S; Ly D; Nieto J; Kanwal F; Lu D; Raman S; Amado R; Nuesse B; Durazo F; Han S; Farmer DG; Ghobrial RM; Yersiz H; Chen P; Schwegel K; Goldstein LI; Tong M; Busuttil RW
Liver Transpl; 2003 Jul; 9(7):672-81. PubMed ID: 12827551
[TBL] [Abstract][Full Text] [Related]
6. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
[TBL] [Abstract][Full Text] [Related]
7. Surveillance and diagnosis for hepatocellular carcinoma.
Aljabiri MR; Lodato F; Burroughs AK
Liver Transpl; 2007 Nov; 13(11 Suppl 2):S2-12. PubMed ID: 17969087
[No Abstract] [Full Text] [Related]
8. Liver transplantation for hepatocellular carcinoma: is expansion of criteria justified?
Roayaie S; Llovet JM
Clin Liver Dis; 2005 May; 9(2):315-28. PubMed ID: 15831276
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection of hepatocellular carcinoma.
Duffy JP; Hiatt JR; Busuttil RW
Cancer J; 2008; 14(2):100-10. PubMed ID: 18391615
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
11. Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers.
Iizuka N; Oka M; Sakaida I; Moribe T; Miura T; Kimura N; Tamatsukuri S; Ishitsuka H; Uchida K; Terai S; Yamashita S; Okita K; Sakata K; Karino Y; Toyota J; Ando E; Ide T; Sata M; Tsunedomi R; Tsutsui M; Iida M; Tokuhisa Y; Sakamoto K; Tamesa T; Fujita Y; Hamamoto Y
Clin Chim Acta; 2011 Jan; 412(1-2):152-8. PubMed ID: 20883676
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C.
Lin OS; Keeffe EB; Sanders GD; Owens DK
Aliment Pharmacol Ther; 2004 Jun; 19(11):1159-72. PubMed ID: 15153169
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
[TBL] [Abstract][Full Text] [Related]
14. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
[TBL] [Abstract][Full Text] [Related]
15. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics of hepatocellular carcinoma in patients with antibody to hepatitis C virus].
Nagoshi S; Fujiwara K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):615-8. PubMed ID: 15359871
[No Abstract] [Full Text] [Related]
17. Liver transplantation in patients with hepatocellular carcinoma.
Schwartz M
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S81-5. PubMed ID: 14762845
[TBL] [Abstract][Full Text] [Related]
18. [Surgical therapy of hepatic fibrolamellar carcinoma].
Meriggi F; Forni E
Ann Ital Chir; 2007; 78(1):53-8. PubMed ID: 17518332
[TBL] [Abstract][Full Text] [Related]
19. Can hepatocellular cancer screening increase the proportion of long-term survivors?
Gannon CJ; Izzo F; Aloia TA; Pignata S; Nasti G; Vallone P; Orlando R; Scordino F; Curley SA
Hepatogastroenterology; 2009; 56(93):1152-6. PubMed ID: 19760960
[TBL] [Abstract][Full Text] [Related]
20. [Tumor markers for hepatocellular carcinoma].
Fujiyama S; Tanaka M; Maeda S; Ashihara H; Hirata R
Gan To Kagaku Ryoho; 2001 May; 28(5):723-32. PubMed ID: 11383225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
